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LETTER TO THE EDITOR

Oral mucormycosis in post-COVID-19 patients: A case series
The current COVID-19 pandemic has thrown up yet an extra chal-

Therefore, a non-specific palatal ulcer could be considered as

lenge for health care, with some cases of an uncommon fungal in-

the presenting sign of mucormycosis, and it is necessary for a dental

fection being described, which are associated with increased death

practitioner to be alert to initial signs and symptoms of this disease,

rate. COVID-19 patients are predisposed to developing fungal infec-

specifically when evaluating the high-risk patients. Early diagnosis of

tions as mucormycosis, which has been described from those still

mucormycosis is critical, as treatment should start as soon as possi-

battling, and those who recently convalesced, especially medically

ble in an attempt to decrease mortality (Sanath et al., 2020).

compromised patients. This could be attributed to the reduction in

The role of dentists is critical because mucormycosis primarily

CD4+ T cells and CD8+ T cells causing immune suppression. The

occurs around rhinomaxillary or rhinocerebral areas involving facial

illness usually progresses rapidly in debilitated or immunocompro-

tissues, palate, alveolar bone, and mandibular bone. Therefore, den-

mised patients. Recent rise in the incidence of rhinomaxillary mucor-

tal professionals should be mindful of symptoms of mucormycosis.

mycosis has been noticed and has become an emergency presume

In addition to palatal lesions, atypical symptoms such as sinus pain,

(Krishna et al., 2021).

facial pain, unanticipated odontalgia of otherwise sound teeth, or

The rise of mucormycosis in COVID-19 patients is predisposed

patient deterioration after dental therapeutic interventions should

by trauma, poorly controlled diabetes, the unnecessary use of cor-

alert clinicians to seek confirmation of the diagnosis and promptly

ticosteroids, prolonged neutropenia, hemopoietic malignancies, he-

start optimal treatment (Bains & Hosseini-Ardehali, 2005).

matopoietic stem cell transplant, organ transplant, and prolonged
stays in the intensive care unit (Raut & Huy, 2021).

Finally, it is noteworthy that although the recent rise of mucormycosis occurring concurrently with COVID-19, it is not conceiv-

Oral lesions seen in COVID-19 patients are more probably

able to state that there is a causal association between the two

caused by co-infections, adverse reactions, and immunity impair-

conditions, but this is rather due to the presence of many factors

ment instead of direct COVID-19 infection. Not every disease that

and conditions related to the pandemic setting that predispose to

occurs in the pandemic times is due to COVID-19 (Anaya-Saavedra,
2021; Rawson et al., 2020).
In a recent systematic review, it was stated that 8% of patients
suffered from fungal or bacterial co-infection through hospitalization. Co-infections mostly occur when the patients themselves are
already loaded by the infective organism before the viral infection,
when patients suffer from an underlying persistent infection, or
when patients are hospitalized (Rawson et al., 2020).
We would like to report 21 post-COVID-19 patients (14 days
after recovery) who had oral mucormycosis (11 [52.4%] males and
10 [47.6%] females) with mean age (58 ± 12) years with no significant
difference.
Figure 1 is showing the descriptive data of palatal lesions among
the post-COVID-19 patients with oral mucormycosis.
Oral manifestations of mucormycosis in COVID-19 patients are
usually seen in the palate and may include varying degrees of mucosal discoloration, swelling, ulcerations, superficial necrotic areas in
the palate (Figure 1), bone exposure and necrosis with dark eschar
formation (Brandao et al., 2020). Hence, palatal ulcerations could
be the first presenting symptom, leading the patient to the dentist,
who can be the first clinician to suspect an infection leading to the
diagnosis of mucormycosis (Brandao et al., 2020; Amorim dos Santos
et al., 2021).
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F I G U R E 1 The left side of the hard palate showing deep
necrotic ulcer
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